Tejon Ranch TRC Q1 2026 Earnings 001 EPS Surges Past 002 Estimates Scope for Meaningful Rate Cuts Ahead Says Credit Suisses Neelkanth Mishra Federal Reserve Signals Cautious Approach Amid Economic Uncertainty Trump Regrets Not Seeking Larger Intel Stake as Shares Surge Credit Saison India Secures 500 Million in Landmark External Borrowing to Accelerate MSME and Secured Lending Expansion Google Unveils New Smart Glasses with AI Integration Marking Return to Wearable Market MUFG Q1 2026 Earnings Strong Earnings Beat Signals Resilience in Japanese Banking Anthropics Share Ban Shakes PreIPO Market Triggers Investor Panic Fiserv Pursues Constant Compounder Comeback with Clover AI and Banking Push Tech Stock Decline Viewed as Potential Buying Opportunity by Historical Patterns Crypto Industry Braces for the Evolving Threat of Quantum Computing Ledn Projects 1 Trillion Potential in BitcoinBacked Lending Market Nvidias 2400 Dividend Hike Still Highlights Growth Over Income Disneys The Mandalorian and Grogu Opens to 82 Million Weakest Star Wars Debut Yet CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase IHT Q1 2026 Earnings Modest Loss Reflects Challenging Start to Fiscal Year UMBFO Q1 2026 Earnings Strong EPS Beat Signals Resilience Despite Revenue Disclosure Gap SO Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher VMD Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges AI Infrastructure and Energy Plays Outperform Nvidia in Recent Market Trends Oil Prices Rebound Above 100 as USIran Tensions Resurface Nvidia Earnings Spotlight Jensen Huangs Commentary on China and Trump Relations Could Move Markets Top Healthcare Fund Increases Stake in Soaring Biotech Firm Oil Prices Retreat as Scope for USIran Peace Talks Emerges Brent Crude at 98bbl Oil Prices Decline Equities Rise on Hopes for Iran Nuclear Talks Progress Russias State Duma Passes Law Allowing Central Bank to Operate AntiDrone Systems Upstream Bio Inc UPB Q1 2026 Earnings Narrowed Loss Per Share as Clinical Pipeline Advances